<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Dyne Therapeutics annuncia il via libera da parte della FDA per la richiesta di nuovo farmaco per DYNE-251 per il trattamento della distrofia muscolare di Duchenne	</title>
	<atom:link href="https://www.parentproject.it/2022/07/11/dyne-therapeutics-annuncia-il-via-libera-da-parte-della-fda-per-la-richiesta-di-nuovo-farmaco-per-dyne-251-per-il-trattamento-della-distrofia-muscolare-di-duchenne/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.parentproject.it/2022/07/11/dyne-therapeutics-annuncia-il-via-libera-da-parte-della-fda-per-la-richiesta-di-nuovo-farmaco-per-dyne-251-per-il-trattamento-della-distrofia-muscolare-di-duchenne/</link>
	<description>Insieme per fermare la Duchenne e la Becker</description>
	<lastBuildDate>Mon, 11 Jul 2022 07:46:36 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
